1. [Three cases of gastric cancer treated by S-1 combined with docetaxel in place of cisplatin]
- Author
-
Hideaki, Ganno, Yoshihisa, Watayo, Hidetoshi, Amagasa, Toshiya, Ohhara, Kenichiroh, Hataji, Norihito, Kawasaki, Toshiaki, Kurokawa, Katsunori, Ami, Akira, Fukuda, Takeshi, Nagahama, Masahiro, Ando, and Kuniyoshi, Arai
- Subjects
Male ,Antimetabolites, Antineoplastic ,Antineoplastic Agents ,Docetaxel ,Middle Aged ,Drug Combinations ,Oxonic Acid ,Stomach Neoplasms ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Female ,Taxoids ,Cisplatin ,Aged ,Tegafur - Abstract
Although combination of S-1 and cisplatin (CDDP) is a standard therapy for advance or recurrent gastric cancer patients, there are some cases where a CDDP administration is difficult for patients. We here report three such cases of gastric cancer treated by S-1 and docetaxel (DOC) combination therapy. Based on our three cases, we believe that S-1 and DOC combination therapy could be suitable for outpatients showing safety and efficacy.
- Published
- 2011